Bristol Myers Colorectal Cancer Treatment Goes Under Priority FDA Review
Bristol-Myers Squibb Co. · PHARMACEUTICAL PREPARATIONS · Now $57.18
+2.0% in 3d after detection
Post-detection moves
1h
—
1d
+0.4%
3d
+2.0%
7d
-1.9%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS